The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

 ARIAD Pharmaceuticals Inc  (ARIA) Trade Now »     Rate ARIA  -  Discuss ARIA  -  Add to Watch List         Graphic_subscribe

       Sector: Healthcare  >  Industry: Biotechnology & Drugs
SocialPicks Sentiment:

** v.s. other stocks 		This Quarter's Sentiment:
All:
89.0%
Top:
100.0%
Rate ARIA:


Home
Analysis & Videos
Quotes
Bull or Bear
Discuss
        

ARIA: Bull or Bear? From:    SocialPicks  |  Blogsphere  |  All

SocialPicks Community

ARIA Graphic_rating_buy ARIA
N/A
 +5.53%
in 10 days
(closed on 09/18/09)
Aria should be up this week, their new drugs may be out in 9th september according to some people said.
By  grand_dra9on   (-16.84%  risk: conservative)  09/08/09 Comment




From the Blogosphere

Analyst upgrades, downgrades and initiations: ANF, AZN, BX, GPS, PH, RAIL, VRSN ...

Filed under: Analyst reports, Analyst upgrades and downgrades, Analyst initiations

Analyst upgrades:

<>
  • Keefe Bruyette upgraded Blackstone Group (BX) to outperform from market perform following the company's Q3 results and maintains an $18.50 price target on shares.
  • Baird upgraded Astec (ASTE) to outperform from neutral citing relative valuation and upside from new multi-year U.S. highway funding legislation. The firm raised its target to $33 from $27.
    • <>Goldman upgraded Abercrombie & Fitch (ANF) to conviction buy from neutral citing "significant" long-term growth drivers that include ...
    By  Blogging Stocks    11/09/09 Comment


    Ariad’s AP24534 in Publication (NASDAQ:ARIA)
    Logo1
    38%
    Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) today announced that Cancer Cell, one of the leading scientific journals, has published a comprehensive paper describing the design and preclinical characterization of an investigational kinase inhibitor (AP24534). The paper mentions ...
    By  StraightStocks   (-6.98%  risk: moderate)  11/03/09 Comment


    Mercer International Pops 50%, but Repros Therapeutics down 14%
    Stop
    56%
    Mercer International (MERC) 52% HIGHER; since announcing it's Q2 results on July 29, share of Mercer have skyrocketed more than 340%.

    ARIAD Pharmaceuticals Inc. (ARIA) 5% HIGHER;     rose after the close on Friday. This morning's report was that ARIAD and its co-plaintiffs announced that the Court of Appeals granted their petition for rehearing 'En Banc' in the Lilly NF-kB patent lawsuit. Shares were up about 2% at $2.17 as many traders sold the news.

    Electro-Optical Sciences, Inc. (MELA) 19% HIGHER; was a big winner after being featured in this weekend's "unusual suspects" after Barron's highli...
    By  s J   (-16.23%  risk: aggressive)  08/25/09 Comment


    Ariad Pharmaceuticals: Significant Catalysts Approaching
    In the coming weeks, Ariad Pharmaceuticals (ARIA) is expected to announce the first interim analysis for the Phase 3 trial for ridaforolimus (rida), an mTOR inhibitor therapeutic indicated for soft tissue and bone sarcomas – aggressive, less common cancers that attack healthy connective tissue.
    click to enlarge
    <>
    Based on my analysis of past outcomes from other successful cancer drugs, I am willing to wager that the Phase 3 results will confirm that rida is a safe and effective oral cancer treatment.

    <>From all existing data, there is a high probability that rida will obtain FDA approval after ...
    By  trackseekingalpha   (-11.47%  risk: aggressive)  08/14/09 Comment


    Small Cancer Drug Makers Are on Fire
    In case some didn’t get the memo, the smaller drug makers have been on fire this summer.

    On July 7, the Lucky 13 Buys list was unleashed. Since that time, SuperGen (SUPG) and Ariad Pharamaceuticals (ARIA) have each topped the list with gains of 45% and 85%, respectively. In recent sessions, both SUPG and ARIA have pulled back.

    On Monday August 3, Lucky 13 Buys was a mere four weeks old. So far, the results have been impressive and far exceeding prior expectations. Five have advanced more than 30%. Nine are up over 20%, and 12 of the Lucky 13 Buys have increased by more than 13%.

    By  trackseekingalpha   (-11.47%  risk: aggressive)  08/04/09 Comment



    ROCK-STAR INVESTORS
    Rank Name Sharpe Ratio Avg Return Followers
    1 noshoes 21.10 +34.25% 378
    2 Gerald Greene 18.14 +70.10% 208
    3 stockmarketfunding.com 17.66 +25.70% 55
    4 akiralegrand 13.47 +14.32% 61
    5 anup2104 12.13 +75.30% 38


    POPULAR STOCKS
    Symbol Company Name Sentiment
    WM Washington Mutual Inc
    GS Goldman Sachs Group Inc The
    AMD Advanced Micro Devices Inc
    MSFT Microsoft Corp
    AMZN Amazoncom Inc
    GM General Motors Corp

    TODAY'S HEADLINES

    TODAY'S TOP PICKS

    		 

    StreetInsider.com on ARIA

    Visit streetinsider.com


    Discussion Wall + Add  
    amritadas   (+0.00%)
    Free report on upcoming FDA panel decision of Corvu.. - FDA Panel to review this Biotech company's stress agent drug on July 28th. If they get a favorable backing by the panel, the chances of approval by th...
    +   0 replies


    More Resources

    Graphic_arrow1 About ARIAD Pharmaceuticals Inc - Answers.com

    Graphic_arrow1 Historical Prices - Yahoo

    Graphic_arrow1 Message Boards - BoardCentral.com

    Graphic_arrow1 More Info:     Yahoo   |   Google   |   Reuters




    		IN THE PRESS
    Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch